Bruce Cozadd
Board Member
Jazz Pharmaceuticals plc (JAZZ)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Bruce Cozadd
Bruce Cozadd is recorded as Board Member and CEO at Jazz Pharmaceuticals plc (JAZZ). The proxy statement of Jazz Pharmaceuticals plc reports total compensation of $18,834,836 for Bruce Cozadd in fiscal 2025, including a base salary of $884,789. Disclosed compensation is on record for 9 fiscal years. Bruce Cozadd has spoken on 22 earnings calls across 1 company, most recently for Jazz Pharmaceuticals plc on August 27, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Jazz Pharmaceuticals plc
Other people whose current roles at this company are on record from its filings.
- Renee D. Gala CEO
- Renee Gala CEO, COO, Board Member
- Matthew P. Young CFO
- Philip Johnson CFO
- Renée D. Galá CFO
- Chris Tovey COO
- Renée Galá COO
- Neena M. Patil General Counsel
- Patricia Carr Chief Accounting Officer
- Anne O’Riordan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Jazz Pharmaceuticals plc (JAZZ) | Chairperson and former CEO | $884,789 | $18,834,836 |
| 2024 | Jazz Pharmaceuticals plc (JAZZ) | Chairperson and CEO | $1,203,514 | $15,527,464 |
| 2023 | Jazz Pharmaceuticals plc (JAZZ) | Chairperson and CEO | $1,196,621 | $15,341,235 |
| 2022 | Jazz Pharmaceuticals plc (JAZZ) | Chairperson and CEO | $1,199,169 | $17,325,618 |
| 2021 | Jazz Pharmaceuticals plc (JAZZ) | Chairperson and CEO | $1,077,254 | $15,679,311 |
| 2020 | Jazz Pharmaceuticals plc (JAZZ) | Chairperson and CEO | $1,085,123 | $12,573,300 |
| 2019 | Jazz Pharmaceuticals plc (JAZZ) | Chairperson and CEO | $1,014,415 | $14,713,637 |
| 2018 | Jazz Pharmaceuticals plc (JAZZ) | Chairman and CEO | $979,285 | $11,443,133 |
| 2017 | Jazz Pharmaceuticals plc (JAZZ) | Chairman and CEO | $950,385 | $10,304,610 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.